Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Aim: To confirm the efficacy of vildagliptin in patients with type 2 diabetes (T2D) by testing the hypothesis that glycosylated haemoglobin (HbA1c) reduction with vildagliptin is superior to that with voglibose after 12 weeks of treatment. Methods: In this 12-week, randomized, double-blind, active-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Y, Kashiwagi, A, Yamada, N, Terao, S, Mimori, N, Suzuki, M, Tachibana, H
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916214/
https://www.ncbi.nlm.nih.gov/pubmed/20590747
http://dx.doi.org/10.1111/j.1463-1326.2010.01222.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916214/
https://www.ncbi.nlm.nih.gov/pubmed/20590747
http://dx.doi.org/10.1111/j.1463-1326.2010.01222.x

Ejemplares similares